WARNING! More information in the Privacy Policy and the use of cookies Mission of the company In line with the mission, BIOTON aims to strengthen its position as a global biotechnology company. Participation in scientific and research projects, development of the product portfolio and business decisions made enable the implementation of strategic goals and result from the broadly understood concern for the quality of health and life of patients. The implementation of the chosen mission is supported by the development directions and strategic activities adopted by BIOTON, which include: strengthening the position of BIOTON on the Polish insulin market, strengthening the position of BIOTON insulin in the world by increasing the sales share on the existing markets and entering new ones, development of innovative, clinically important drugs, including biotechnological drugs, developed by entities belonging to the BIOTON Group, expanding the portfolio of generic drugs. About company Mission of the company Authorities of BIOTON SA History of BIOTON SA Research and development Quality management Sales targets and global expansion Companies of the BIOTON SA Group Cooperation with the European Union Press office Privacy policy and the use of cookies contact AVAILABILITY OF GENSUPEN Press office Contact for media: Renata Ożarowska ozarowskar@bioton.pl Tel .: +22 721 40 02 Contact for investors: Renata Ożarowska ozarowskar@bioton.pl Tel .: +22 721 40 02 © 2016 BIOTON SA phone: +48 22 721 40 00 fax: +48 22 721 13 33 bioinfo@bioton.pl